nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Temozolomide—melanoma	0.183	0.576	CbGbCtD
Tadalafil—PDE5A—clitoris—melanoma	0.149	0.728	CbGeAlD
Tadalafil—CYP3A4—Vemurafenib—melanoma	0.1	0.316	CbGbCtD
Tadalafil—CYP3A4—Docetaxel—melanoma	0.0343	0.108	CbGbCtD
Tadalafil—PDE5A—endothelium—melanoma	0.0165	0.0806	CbGeAlD
Tadalafil—PDE5A—blood vessel—melanoma	0.0152	0.0744	CbGeAlD
Tadalafil—PDE5A—eye—melanoma	0.0081	0.0396	CbGeAlD
Tadalafil—PDE5A—retina—melanoma	0.00802	0.0392	CbGeAlD
Tadalafil—PDE5A—head—melanoma	0.0046	0.0225	CbGeAlD
Tadalafil—PDE5A—lymph node—melanoma	0.00322	0.0157	CbGeAlD
Tadalafil—Nervous system disorder—Vemurafenib—melanoma	0.00162	0.00432	CcSEcCtD
Tadalafil—Skin disorder—Vemurafenib—melanoma	0.00161	0.00428	CcSEcCtD
Tadalafil—Breast disorder—Temozolomide—melanoma	0.00156	0.00414	CcSEcCtD
Tadalafil—Acute coronary syndrome—Bleomycin—melanoma	0.00155	0.00413	CcSEcCtD
Tadalafil—Hypotension—Vemurafenib—melanoma	0.00155	0.00412	CcSEcCtD
Tadalafil—Myocardial infarction—Bleomycin—melanoma	0.00154	0.00411	CcSEcCtD
Tadalafil—Dysphagia—Carmustine—melanoma	0.00154	0.0041	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00151	0.00402	CcSEcCtD
Tadalafil—Haematuria—Bleomycin—melanoma	0.0015	0.00399	CcSEcCtD
Tadalafil—Dysphagia—Temozolomide—melanoma	0.00149	0.00396	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00145	0.00387	CcSEcCtD
Tadalafil—Oesophagitis—Docetaxel—melanoma	0.00144	0.00384	CcSEcCtD
Tadalafil—Bronchitis—Temozolomide—melanoma	0.00143	0.00381	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Vemurafenib—melanoma	0.00143	0.00381	CcSEcCtD
Tadalafil—Fatigue—Vemurafenib—melanoma	0.00143	0.0038	CcSEcCtD
Tadalafil—Haemoglobin—Bleomycin—melanoma	0.00142	0.00378	CcSEcCtD
Tadalafil—Constipation—Vemurafenib—melanoma	0.00142	0.00377	CcSEcCtD
Tadalafil—Haemorrhage—Bleomycin—melanoma	0.00141	0.00376	CcSEcCtD
Tadalafil—Hypoaesthesia—Bleomycin—melanoma	0.0014	0.00374	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Temozolomide—melanoma	0.00138	0.00368	CcSEcCtD
Tadalafil—Renal failure—Carmustine—melanoma	0.00135	0.00359	CcSEcCtD
Tadalafil—Urinary tract infection—Carmustine—melanoma	0.00133	0.00355	CcSEcCtD
Tadalafil—Infestation—Temozolomide—melanoma	0.00133	0.00353	CcSEcCtD
Tadalafil—Infestation NOS—Temozolomide—melanoma	0.00133	0.00353	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00131	0.0035	CcSEcCtD
Tadalafil—Flushing—Bleomycin—melanoma	0.00131	0.00349	CcSEcCtD
Tadalafil—Pharyngitis—Dactinomycin—melanoma	0.00131	0.00348	CcSEcCtD
Tadalafil—Swelling—Docetaxel—melanoma	0.0013	0.00346	CcSEcCtD
Tadalafil—Urinary tract infection—Temozolomide—melanoma	0.00129	0.00344	CcSEcCtD
Tadalafil—Deafness—Docetaxel—melanoma	0.00128	0.00341	CcSEcCtD
Tadalafil—Erythema multiforme—Dactinomycin—melanoma	0.00124	0.00332	CcSEcCtD
Tadalafil—Haemoglobin—Carmustine—melanoma	0.00124	0.0033	CcSEcCtD
Tadalafil—Haemorrhage—Carmustine—melanoma	0.00123	0.00328	CcSEcCtD
Tadalafil—Hypoaesthesia—Carmustine—melanoma	0.00123	0.00327	CcSEcCtD
Tadalafil—Hot flush—Docetaxel—melanoma	0.00122	0.00326	CcSEcCtD
Tadalafil—Flushing—Dactinomycin—melanoma	0.00122	0.00326	CcSEcCtD
Tadalafil—Hypersensitivity—Vemurafenib—melanoma	0.00122	0.00325	CcSEcCtD
Tadalafil—Oedema peripheral—Carmustine—melanoma	0.00121	0.00323	CcSEcCtD
Tadalafil—Menopausal symptoms—Docetaxel—melanoma	0.00121	0.00323	CcSEcCtD
Tadalafil—Connective tissue disorder—Carmustine—melanoma	0.00121	0.00323	CcSEcCtD
Tadalafil—Renal impairment—Docetaxel—melanoma	0.0012	0.0032	CcSEcCtD
Tadalafil—Haemoglobin—Temozolomide—melanoma	0.0012	0.00319	CcSEcCtD
Tadalafil—Haemorrhage—Temozolomide—melanoma	0.00119	0.00317	CcSEcCtD
Tadalafil—Asthenia—Vemurafenib—melanoma	0.00119	0.00316	CcSEcCtD
Tadalafil—Hypoaesthesia—Temozolomide—melanoma	0.00118	0.00316	CcSEcCtD
Tadalafil—Pharyngitis—Temozolomide—melanoma	0.00118	0.00315	CcSEcCtD
Tadalafil—Urinary tract disorder—Temozolomide—melanoma	0.00118	0.00313	CcSEcCtD
Tadalafil—Oedema peripheral—Temozolomide—melanoma	0.00117	0.00313	CcSEcCtD
Tadalafil—Pruritus—Vemurafenib—melanoma	0.00117	0.00312	CcSEcCtD
Tadalafil—Connective tissue disorder—Temozolomide—melanoma	0.00117	0.00312	CcSEcCtD
Tadalafil—Urethral disorder—Temozolomide—melanoma	0.00117	0.00311	CcSEcCtD
Tadalafil—Eye disorder—Carmustine—melanoma	0.00115	0.00307	CcSEcCtD
Tadalafil—Pain in extremity—Docetaxel—melanoma	0.00114	0.00305	CcSEcCtD
Tadalafil—Flushing—Carmustine—melanoma	0.00114	0.00305	CcSEcCtD
Tadalafil—Diarrhoea—Vemurafenib—melanoma	0.00113	0.00302	CcSEcCtD
Tadalafil—Migraine—Docetaxel—melanoma	0.00113	0.003	CcSEcCtD
Tadalafil—Erythema multiforme—Temozolomide—melanoma	0.00113	0.003	CcSEcCtD
Tadalafil—Eye disorder—Temozolomide—melanoma	0.00111	0.00296	CcSEcCtD
Tadalafil—Tinnitus—Temozolomide—melanoma	0.00111	0.00296	CcSEcCtD
Tadalafil—Cardiac disorder—Temozolomide—melanoma	0.0011	0.00294	CcSEcCtD
Tadalafil—Flushing—Temozolomide—melanoma	0.0011	0.00294	CcSEcCtD
Tadalafil—Dizziness—Vemurafenib—melanoma	0.00109	0.00292	CcSEcCtD
Tadalafil—Angiopathy—Temozolomide—melanoma	0.00108	0.00288	CcSEcCtD
Tadalafil—Mental disorder—Carmustine—melanoma	0.00108	0.00288	CcSEcCtD
Tadalafil—Immune system disorder—Temozolomide—melanoma	0.00108	0.00287	CcSEcCtD
Tadalafil—Mediastinal disorder—Temozolomide—melanoma	0.00107	0.00286	CcSEcCtD
Tadalafil—Cough—Bleomycin—melanoma	0.00107	0.00286	CcSEcCtD
Tadalafil—Liver function test abnormal—Docetaxel—melanoma	0.00106	0.00282	CcSEcCtD
Tadalafil—Vomiting—Vemurafenib—melanoma	0.00105	0.0028	CcSEcCtD
Tadalafil—Chest pain—Bleomycin—melanoma	0.00105	0.00279	CcSEcCtD
Tadalafil—Myalgia—Bleomycin—melanoma	0.00105	0.00279	CcSEcCtD
Tadalafil—Orthostatic hypotension—Docetaxel—melanoma	0.00105	0.00279	CcSEcCtD
Tadalafil—Abdominal pain upper—Docetaxel—melanoma	0.00105	0.00279	CcSEcCtD
Tadalafil—Rash—Vemurafenib—melanoma	0.00104	0.00278	CcSEcCtD
Tadalafil—Mental disorder—Temozolomide—melanoma	0.00104	0.00278	CcSEcCtD
Tadalafil—Dermatitis—Vemurafenib—melanoma	0.00104	0.00278	CcSEcCtD
Tadalafil—Back pain—Carmustine—melanoma	0.00104	0.00276	CcSEcCtD
Tadalafil—Headache—Vemurafenib—melanoma	0.00104	0.00276	CcSEcCtD
Tadalafil—Breast disorder—Docetaxel—melanoma	0.00103	0.00276	CcSEcCtD
Tadalafil—Discomfort—Bleomycin—melanoma	0.00103	0.00275	CcSEcCtD
Tadalafil—Nasopharyngitis—Docetaxel—melanoma	0.00102	0.00273	CcSEcCtD
Tadalafil—Vision blurred—Carmustine—melanoma	0.00101	0.00269	CcSEcCtD
Tadalafil—Oedema—Bleomycin—melanoma	0.001	0.00267	CcSEcCtD
Tadalafil—Back pain—Temozolomide—melanoma	0.001	0.00267	CcSEcCtD
Tadalafil—Infection—Bleomycin—melanoma	0.000996	0.00265	CcSEcCtD
Tadalafil—Dysphagia—Docetaxel—melanoma	0.000989	0.00264	CcSEcCtD
Tadalafil—Nausea—Vemurafenib—melanoma	0.000983	0.00262	CcSEcCtD
Tadalafil—Vision blurred—Temozolomide—melanoma	0.000977	0.0026	CcSEcCtD
Tadalafil—Myalgia—Dactinomycin—melanoma	0.000976	0.0026	CcSEcCtD
Tadalafil—Discomfort—Dactinomycin—melanoma	0.000964	0.00257	CcSEcCtD
Tadalafil—Angina pectoris—Docetaxel—melanoma	0.000964	0.00257	CcSEcCtD
Tadalafil—Angioedema—Temozolomide—melanoma	0.000947	0.00252	CcSEcCtD
Tadalafil—Hypotension—Bleomycin—melanoma	0.000937	0.0025	CcSEcCtD
Tadalafil—Oedema—Dactinomycin—melanoma	0.000935	0.00249	CcSEcCtD
Tadalafil—Vertigo—Temozolomide—melanoma	0.000931	0.00248	CcSEcCtD
Tadalafil—Convulsion—Carmustine—melanoma	0.000929	0.00248	CcSEcCtD
Tadalafil—Infection—Dactinomycin—melanoma	0.000929	0.00248	CcSEcCtD
Tadalafil—Hypertension—Carmustine—melanoma	0.000926	0.00247	CcSEcCtD
Tadalafil—Palpitations—Temozolomide—melanoma	0.000916	0.00244	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000914	0.00243	CcSEcCtD
Tadalafil—Chest pain—Carmustine—melanoma	0.000913	0.00243	CcSEcCtD
Tadalafil—Myalgia—Carmustine—melanoma	0.000913	0.00243	CcSEcCtD
Tadalafil—Cough—Temozolomide—melanoma	0.000904	0.00241	CcSEcCtD
Tadalafil—Paraesthesia—Bleomycin—melanoma	0.0009	0.0024	CcSEcCtD
Tadalafil—Convulsion—Temozolomide—melanoma	0.000898	0.00239	CcSEcCtD
Tadalafil—Hypertension—Temozolomide—melanoma	0.000895	0.00238	CcSEcCtD
Tadalafil—Dyspnoea—Bleomycin—melanoma	0.000894	0.00238	CcSEcCtD
Tadalafil—Arthralgia—Temozolomide—melanoma	0.000882	0.00235	CcSEcCtD
Tadalafil—Myalgia—Temozolomide—melanoma	0.000882	0.00235	CcSEcCtD
Tadalafil—Infestation—Docetaxel—melanoma	0.000882	0.00235	CcSEcCtD
Tadalafil—Infestation NOS—Docetaxel—melanoma	0.000882	0.00235	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000876	0.00233	CcSEcCtD
Tadalafil—Oedema—Carmustine—melanoma	0.000875	0.00233	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000874	0.00233	CcSEcCtD
Tadalafil—Discomfort—Temozolomide—melanoma	0.000872	0.00232	CcSEcCtD
Tadalafil—Infection—Carmustine—melanoma	0.00087	0.00232	CcSEcCtD
Tadalafil—Acute coronary syndrome—Docetaxel—melanoma	0.000869	0.00232	CcSEcCtD
Tadalafil—Renal failure—Docetaxel—melanoma	0.000867	0.00231	CcSEcCtD
Tadalafil—Myocardial infarction—Docetaxel—melanoma	0.000865	0.0023	CcSEcCtD
Tadalafil—Dry mouth—Temozolomide—melanoma	0.000863	0.0023	CcSEcCtD
Tadalafil—Pain—Bleomycin—melanoma	0.000858	0.00228	CcSEcCtD
Tadalafil—Conjunctivitis—Docetaxel—melanoma	0.000857	0.00228	CcSEcCtD
Tadalafil—Tachycardia—Carmustine—melanoma	0.000854	0.00228	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000852	0.00227	CcSEcCtD
Tadalafil—Oedema—Temozolomide—melanoma	0.000846	0.00225	CcSEcCtD
Tadalafil—Infection—Temozolomide—melanoma	0.00084	0.00224	CcSEcCtD
Tadalafil—Epistaxis—Docetaxel—melanoma	0.000832	0.00222	CcSEcCtD
Tadalafil—Nervous system disorder—Temozolomide—melanoma	0.00083	0.00221	CcSEcCtD
Tadalafil—Skin disorder—Temozolomide—melanoma	0.000822	0.00219	CcSEcCtD
Tadalafil—Hypotension—Carmustine—melanoma	0.000818	0.00218	CcSEcCtD
Tadalafil—Hyperhidrosis—Temozolomide—melanoma	0.000818	0.00218	CcSEcCtD
Tadalafil—Fatigue—Dactinomycin—melanoma	0.000806	0.00215	CcSEcCtD
Tadalafil—Pain—Dactinomycin—melanoma	0.0008	0.00213	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Carmustine—melanoma	0.000797	0.00212	CcSEcCtD
Tadalafil—Urticaria—Bleomycin—melanoma	0.000797	0.00212	CcSEcCtD
Tadalafil—Haemoglobin—Docetaxel—melanoma	0.000796	0.00212	CcSEcCtD
Tadalafil—Rhinitis—Docetaxel—melanoma	0.000794	0.00212	CcSEcCtD
Tadalafil—Haemorrhage—Docetaxel—melanoma	0.000792	0.00211	CcSEcCtD
Tadalafil—Insomnia—Carmustine—melanoma	0.000792	0.00211	CcSEcCtD
Tadalafil—Hypoaesthesia—Docetaxel—melanoma	0.000788	0.0021	CcSEcCtD
Tadalafil—Paraesthesia—Carmustine—melanoma	0.000786	0.00209	CcSEcCtD
Tadalafil—Pharyngitis—Docetaxel—melanoma	0.000786	0.00209	CcSEcCtD
Tadalafil—Urinary tract disorder—Docetaxel—melanoma	0.000782	0.00208	CcSEcCtD
Tadalafil—Dyspnoea—Carmustine—melanoma	0.00078	0.00208	CcSEcCtD
Tadalafil—Oedema peripheral—Docetaxel—melanoma	0.00078	0.00208	CcSEcCtD
Tadalafil—Somnolence—Carmustine—melanoma	0.000778	0.00207	CcSEcCtD
Tadalafil—Connective tissue disorder—Docetaxel—melanoma	0.000778	0.00207	CcSEcCtD
Tadalafil—Urethral disorder—Docetaxel—melanoma	0.000776	0.00207	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Temozolomide—melanoma	0.000771	0.00205	CcSEcCtD
Tadalafil—Insomnia—Temozolomide—melanoma	0.000765	0.00204	CcSEcCtD
Tadalafil—Gastrointestinal pain—Dactinomycin—melanoma	0.000765	0.00204	CcSEcCtD
Tadalafil—Paraesthesia—Temozolomide—melanoma	0.00076	0.00202	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Carmustine—melanoma	0.000756	0.00201	CcSEcCtD
Tadalafil—Dyspnoea—Temozolomide—melanoma	0.000754	0.00201	CcSEcCtD
Tadalafil—Somnolence—Temozolomide—melanoma	0.000752	0.002	CcSEcCtD
Tadalafil—Erythema multiforme—Docetaxel—melanoma	0.000749	0.00199	CcSEcCtD
Tadalafil—Constipation—Carmustine—melanoma	0.000749	0.00199	CcSEcCtD
Tadalafil—Pain—Carmustine—melanoma	0.000749	0.00199	CcSEcCtD
Tadalafil—Dyspepsia—Temozolomide—melanoma	0.000745	0.00198	CcSEcCtD
Tadalafil—Eye disorder—Docetaxel—melanoma	0.00074	0.00197	CcSEcCtD
Tadalafil—Abdominal pain—Dactinomycin—melanoma	0.000739	0.00197	CcSEcCtD
Tadalafil—Hypersensitivity—Bleomycin—melanoma	0.000739	0.00197	CcSEcCtD
Tadalafil—Flushing—Docetaxel—melanoma	0.000735	0.00196	CcSEcCtD
Tadalafil—Cardiac disorder—Docetaxel—melanoma	0.000735	0.00196	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Temozolomide—melanoma	0.00073	0.00195	CcSEcCtD
Tadalafil—Fatigue—Temozolomide—melanoma	0.000729	0.00194	CcSEcCtD
Tadalafil—Pain—Temozolomide—melanoma	0.000723	0.00193	CcSEcCtD
Tadalafil—Constipation—Temozolomide—melanoma	0.000723	0.00193	CcSEcCtD
Tadalafil—Asthenia—Bleomycin—melanoma	0.000719	0.00192	CcSEcCtD
Tadalafil—Angiopathy—Docetaxel—melanoma	0.000718	0.00191	CcSEcCtD
Tadalafil—Gastrointestinal pain—Carmustine—melanoma	0.000716	0.00191	CcSEcCtD
Tadalafil—Immune system disorder—Docetaxel—melanoma	0.000715	0.00191	CcSEcCtD
Tadalafil—Mediastinal disorder—Docetaxel—melanoma	0.000714	0.0019	CcSEcCtD
Tadalafil—Pruritus—Bleomycin—melanoma	0.000709	0.00189	CcSEcCtD
Tadalafil—Mental disorder—Docetaxel—melanoma	0.000694	0.00185	CcSEcCtD
Tadalafil—Abdominal pain—Carmustine—melanoma	0.000692	0.00184	CcSEcCtD
Tadalafil—Gastrointestinal pain—Temozolomide—melanoma	0.000692	0.00184	CcSEcCtD
Tadalafil—Hypersensitivity—Dactinomycin—melanoma	0.000689	0.00184	CcSEcCtD
Tadalafil—Urticaria—Temozolomide—melanoma	0.000672	0.00179	CcSEcCtD
Tadalafil—Asthenia—Dactinomycin—melanoma	0.000671	0.00179	CcSEcCtD
Tadalafil—Abdominal pain—Temozolomide—melanoma	0.000669	0.00178	CcSEcCtD
Tadalafil—Back pain—Docetaxel—melanoma	0.000667	0.00178	CcSEcCtD
Tadalafil—Muscle spasms—Docetaxel—melanoma	0.000663	0.00177	CcSEcCtD
Tadalafil—Hypersensitivity—Carmustine—melanoma	0.000645	0.00172	CcSEcCtD
Tadalafil—Diarrhoea—Dactinomycin—melanoma	0.00064	0.0017	CcSEcCtD
Tadalafil—Vomiting—Bleomycin—melanoma	0.000638	0.0017	CcSEcCtD
Tadalafil—Rash—Bleomycin—melanoma	0.000632	0.00168	CcSEcCtD
Tadalafil—Dermatitis—Bleomycin—melanoma	0.000632	0.00168	CcSEcCtD
Tadalafil—Asthenia—Carmustine—melanoma	0.000628	0.00167	CcSEcCtD
Tadalafil—Hypersensitivity—Temozolomide—melanoma	0.000623	0.00166	CcSEcCtD
Tadalafil—Syncope—Docetaxel—melanoma	0.000618	0.00165	CcSEcCtD
Tadalafil—Palpitations—Docetaxel—melanoma	0.000609	0.00162	CcSEcCtD
Tadalafil—Asthenia—Temozolomide—melanoma	0.000607	0.00162	CcSEcCtD
Tadalafil—Loss of consciousness—Docetaxel—melanoma	0.000606	0.00161	CcSEcCtD
Tadalafil—Cough—Docetaxel—melanoma	0.000601	0.0016	CcSEcCtD
Tadalafil—Diarrhoea—Carmustine—melanoma	0.000599	0.0016	CcSEcCtD
Tadalafil—Pruritus—Temozolomide—melanoma	0.000598	0.00159	CcSEcCtD
Tadalafil—Convulsion—Docetaxel—melanoma	0.000597	0.00159	CcSEcCtD
Tadalafil—Nausea—Bleomycin—melanoma	0.000596	0.00159	CcSEcCtD
Tadalafil—Hypertension—Docetaxel—melanoma	0.000595	0.00159	CcSEcCtD
Tadalafil—Vomiting—Dactinomycin—melanoma	0.000595	0.00158	CcSEcCtD
Tadalafil—Rash—Dactinomycin—melanoma	0.00059	0.00157	CcSEcCtD
Tadalafil—Chest pain—Docetaxel—melanoma	0.000587	0.00156	CcSEcCtD
Tadalafil—Arthralgia—Docetaxel—melanoma	0.000587	0.00156	CcSEcCtD
Tadalafil—Myalgia—Docetaxel—melanoma	0.000587	0.00156	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000583	0.00155	CcSEcCtD
Tadalafil—Dizziness—Carmustine—melanoma	0.000579	0.00154	CcSEcCtD
Tadalafil—Diarrhoea—Temozolomide—melanoma	0.000579	0.00154	CcSEcCtD
Tadalafil—Dry mouth—Docetaxel—melanoma	0.000574	0.00153	CcSEcCtD
Tadalafil—Oedema—Docetaxel—melanoma	0.000563	0.0015	CcSEcCtD
Tadalafil—Dizziness—Temozolomide—melanoma	0.000559	0.00149	CcSEcCtD
Tadalafil—Infection—Docetaxel—melanoma	0.000559	0.00149	CcSEcCtD
Tadalafil—Vomiting—Carmustine—melanoma	0.000557	0.00148	CcSEcCtD
Tadalafil—Nausea—Dactinomycin—melanoma	0.000556	0.00148	CcSEcCtD
Tadalafil—Shock—Docetaxel—melanoma	0.000553	0.00147	CcSEcCtD
Tadalafil—Rash—Carmustine—melanoma	0.000552	0.00147	CcSEcCtD
Tadalafil—Nervous system disorder—Docetaxel—melanoma	0.000552	0.00147	CcSEcCtD
Tadalafil—Dermatitis—Carmustine—melanoma	0.000551	0.00147	CcSEcCtD
Tadalafil—Tachycardia—Docetaxel—melanoma	0.000549	0.00146	CcSEcCtD
Tadalafil—Headache—Carmustine—melanoma	0.000548	0.00146	CcSEcCtD
Tadalafil—Skin disorder—Docetaxel—melanoma	0.000546	0.00146	CcSEcCtD
Tadalafil—Vomiting—Temozolomide—melanoma	0.000538	0.00143	CcSEcCtD
Tadalafil—Rash—Temozolomide—melanoma	0.000533	0.00142	CcSEcCtD
Tadalafil—Dermatitis—Temozolomide—melanoma	0.000533	0.00142	CcSEcCtD
Tadalafil—Headache—Temozolomide—melanoma	0.00053	0.00141	CcSEcCtD
Tadalafil—Hypotension—Docetaxel—melanoma	0.000526	0.0014	CcSEcCtD
Tadalafil—Nausea—Carmustine—melanoma	0.00052	0.00139	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000513	0.00137	CcSEcCtD
Tadalafil—Insomnia—Docetaxel—melanoma	0.000509	0.00136	CcSEcCtD
Tadalafil—Paraesthesia—Docetaxel—melanoma	0.000505	0.00135	CcSEcCtD
Tadalafil—Nausea—Temozolomide—melanoma	0.000502	0.00134	CcSEcCtD
Tadalafil—Dyspnoea—Docetaxel—melanoma	0.000502	0.00134	CcSEcCtD
Tadalafil—Somnolence—Docetaxel—melanoma	0.0005	0.00133	CcSEcCtD
Tadalafil—Dyspepsia—Docetaxel—melanoma	0.000495	0.00132	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Docetaxel—melanoma	0.000486	0.00129	CcSEcCtD
Tadalafil—Fatigue—Docetaxel—melanoma	0.000485	0.00129	CcSEcCtD
Tadalafil—Pain—Docetaxel—melanoma	0.000481	0.00128	CcSEcCtD
Tadalafil—Constipation—Docetaxel—melanoma	0.000481	0.00128	CcSEcCtD
Tadalafil—Gastrointestinal pain—Docetaxel—melanoma	0.00046	0.00123	CcSEcCtD
Tadalafil—Abdominal pain—Docetaxel—melanoma	0.000445	0.00118	CcSEcCtD
Tadalafil—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000423	0.00411	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ITGB1—melanoma	0.000422	0.0041	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SYK—melanoma	0.000422	0.0041	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ITGAV—melanoma	0.000414	0.00403	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT3—melanoma	0.000414	0.00403	CbGpPWpGaD
Tadalafil—Hypersensitivity—Docetaxel—melanoma	0.000414	0.0011	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CXCL1—melanoma	0.000411	0.004	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLCB4—melanoma	0.000411	0.004	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IFNA2—melanoma	0.000405	0.00393	CbGpPWpGaD
Tadalafil—Asthenia—Docetaxel—melanoma	0.000404	0.00108	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCR2—melanoma	0.0004	0.00389	CbGpPWpGaD
Tadalafil—Pruritus—Docetaxel—melanoma	0.000398	0.00106	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—RAC2—melanoma	0.000393	0.00382	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—WNT5A—melanoma	0.000387	0.00376	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TRRAP—melanoma	0.000387	0.00376	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CUL3—melanoma	0.000387	0.00376	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—HGF—melanoma	0.000386	0.00375	CbGpPWpGaD
Tadalafil—Diarrhoea—Docetaxel—melanoma	0.000385	0.00103	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CSF2—melanoma	0.000382	0.00371	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ITGB1—melanoma	0.000376	0.00366	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKR1B10—melanoma	0.000376	0.00366	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—F2R—melanoma	0.000375	0.00364	CbGpPWpGaD
Tadalafil—Dizziness—Docetaxel—melanoma	0.000372	0.000991	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—ITGB3—melanoma	0.000366	0.00356	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PRKCA—melanoma	0.000366	0.00356	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDNRB—melanoma	0.000363	0.00352	CbGpPWpGaD
Tadalafil—Vomiting—Docetaxel—melanoma	0.000358	0.000953	CcSEcCtD
Tadalafil—Rash—Docetaxel—melanoma	0.000355	0.000945	CcSEcCtD
Tadalafil—Dermatitis—Docetaxel—melanoma	0.000354	0.000944	CcSEcCtD
Tadalafil—Headache—Docetaxel—melanoma	0.000352	0.000939	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—F2RL1—melanoma	0.00035	0.0034	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—HGF—melanoma	0.000344	0.00334	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GAB2—melanoma	0.000343	0.00333	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GNA11—melanoma	0.000343	0.00333	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000341	0.00332	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CSF2—melanoma	0.00034	0.00331	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2R—melanoma	0.00034	0.0033	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—RAC1—melanoma	0.000339	0.0033	CbGpPWpGaD
Tadalafil—Nausea—Docetaxel—melanoma	0.000334	0.00089	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—EDNRB—melanoma	0.000329	0.0032	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM3—melanoma	0.000329	0.00319	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MMP1—melanoma	0.000328	0.00319	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ITGB3—melanoma	0.000326	0.00317	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PRKCA—melanoma	0.000326	0.00317	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CDK2—melanoma	0.000322	0.00313	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCR4—melanoma	0.000322	0.00313	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GNAQ—melanoma	0.000318	0.00309	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KISS1—melanoma	0.000312	0.00303	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GAB2—melanoma	0.000311	0.00302	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GNA11—melanoma	0.000311	0.00302	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000303	0.00294	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—RAC1—melanoma	0.000303	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR1—melanoma	0.000302	0.00293	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SKI—melanoma	0.000302	0.00293	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FN1—melanoma	0.0003	0.00291	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MC1R—melanoma	0.000297	0.00289	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—melanoma	0.000296	0.00288	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT3—melanoma	0.000294	0.00285	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MMP1—melanoma	0.000293	0.00284	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCR4—melanoma	0.000292	0.00284	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GNAQ—melanoma	0.000289	0.00281	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000289	0.0028	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000288	0.0028	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CDK2—melanoma	0.000287	0.00279	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CG—melanoma	0.000287	0.00279	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM1—melanoma	0.000285	0.00277	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR7—melanoma	0.000285	0.00277	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—EGF—melanoma	0.000283	0.00275	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SUFU—melanoma	0.000278	0.0027	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000275	0.00267	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FN1—melanoma	0.000267	0.00259	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT3—melanoma	0.000267	0.00259	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000264	0.00257	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—melanoma	0.000264	0.00256	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF1—melanoma	0.000263	0.00255	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000261	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RHOB—melanoma	0.000259	0.00252	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BCL2L11—melanoma	0.000259	0.00252	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CG—melanoma	0.000256	0.00248	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—EGF—melanoma	0.000253	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CD—melanoma	0.000252	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HDAC6—melanoma	0.000249	0.00242	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—melanoma	0.000249	0.00242	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDN1—melanoma	0.000247	0.0024	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CSF2—melanoma	0.000241	0.00234	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR2—melanoma	0.000236	0.0023	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF1—melanoma	0.000234	0.00227	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RAC2—melanoma	0.000232	0.00226	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCA—melanoma	0.000231	0.00225	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—WNT5A—melanoma	0.000229	0.00222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFC—melanoma	0.000229	0.00222	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CD—melanoma	0.000225	0.00218	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EDN1—melanoma	0.000224	0.00218	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000222	0.00216	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—melanoma	0.000222	0.00215	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CB—melanoma	0.00022	0.00213	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000219	0.00213	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CSF2—melanoma	0.000219	0.00213	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000217	0.00211	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—RAC1—melanoma	0.000215	0.00208	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000214	0.00208	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCA—melanoma	0.00021	0.00204	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAP2K2—melanoma	0.000205	0.002	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL2—melanoma	0.000202	0.00196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2R—melanoma	0.000201	0.00195	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000201	0.00195	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CB—melanoma	0.000196	0.0019	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RAC1—melanoma	0.000195	0.00189	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDNRB—melanoma	0.000195	0.00189	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTK2B—melanoma	0.000189	0.00183	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GNA11—melanoma	0.000184	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GAB2—melanoma	0.000184	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FLT1—melanoma	0.000183	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CG—melanoma	0.000181	0.00176	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00018	0.00175	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL2—melanoma	0.00018	0.00175	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HDAC2—melanoma	0.000173	0.00168	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR4—melanoma	0.000173	0.00168	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FOXO4—melanoma	0.000173	0.00168	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—melanoma	0.000172	0.00167	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GNAQ—melanoma	0.000171	0.00166	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NRAS—melanoma	0.000169	0.00165	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CG—melanoma	0.000165	0.0016	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MAPK3—melanoma	0.000162	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SYK—melanoma	0.000161	0.00156	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CD—melanoma	0.000159	0.00155	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITGAV—melanoma	0.000158	0.00153	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT3—melanoma	0.000158	0.00153	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGFR—melanoma	0.000158	0.00153	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MAPK1—melanoma	0.000154	0.0015	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—melanoma	0.000153	0.00148	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NRAS—melanoma	0.000151	0.00147	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS1—melanoma	0.000146	0.00142	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—KRAS—melanoma	0.000146	0.00142	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAP2K1—melanoma	0.000146	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—S100B—melanoma	0.000146	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CD—melanoma	0.000145	0.00141	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK3—melanoma	0.000145	0.0014	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB4—melanoma	0.000139	0.00135	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CB—melanoma	0.000139	0.00135	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN2B—melanoma	0.000138	0.00134	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK1—melanoma	0.000138	0.00134	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—melanoma	0.000134	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CD86—melanoma	0.000134	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—melanoma	0.000133	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDN1—melanoma	0.000132	0.00129	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KRAS—melanoma	0.00013	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—melanoma	0.00013	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF1—melanoma	0.000129	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CSF2—melanoma	0.000129	0.00126	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000129	0.00125	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2—melanoma	0.000128	0.00124	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—E2F1—melanoma	0.000127	0.00123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CB—melanoma	0.000126	0.00123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDGFRA—melanoma	0.000125	0.00122	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITGB3—melanoma	0.000124	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCA—melanoma	0.000124	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—HRAS—melanoma	0.000124	0.0012	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SPP1—melanoma	0.000122	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAP2K2—melanoma	0.000121	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—melanoma	0.000121	0.00118	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—melanoma	0.000119	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL2—melanoma	0.000116	0.00113	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—melanoma	0.000115	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TERT—melanoma	0.000115	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RAC1—melanoma	0.000115	0.00112	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000114	0.00111	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.000112	0.00109	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—HRAS—melanoma	0.00011	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—melanoma	0.00011	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—melanoma	0.000109	0.00106	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—melanoma	0.000106	0.00103	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FN1—melanoma	0.000102	0.000987	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH1—melanoma	9.94e-05	0.000966	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—melanoma	9.75e-05	0.000947	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CD80—melanoma	9.74e-05	0.000946	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APC—melanoma	9.72e-05	0.000944	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CG—melanoma	9.72e-05	0.000944	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KIT—melanoma	9.72e-05	0.000944	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NRAS—melanoma	9.72e-05	0.000944	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGF—melanoma	9.61e-05	0.000934	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP1B1—melanoma	9.58e-05	0.00093	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	9.45e-05	0.000918	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAPK3—melanoma	9.31e-05	0.000904	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BRAF—melanoma	9.14e-05	0.000888	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—melanoma	8.9e-05	0.000865	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAPK1—melanoma	8.86e-05	0.000861	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—melanoma	8.86e-05	0.00086	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAP2K1—melanoma	8.6e-05	0.000836	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CD—melanoma	8.55e-05	0.00083	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—melanoma	8.47e-05	0.000822	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KRAS—melanoma	8.37e-05	0.000813	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF2—melanoma	8.18e-05	0.000795	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—melanoma	7.69e-05	0.000747	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MDM2—melanoma	7.66e-05	0.000744	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB2—melanoma	7.55e-05	0.000733	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CB—melanoma	7.45e-05	0.000724	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—melanoma	7.16e-05	0.000695	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRAS—melanoma	7.11e-05	0.000691	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN1B—melanoma	6.99e-05	0.000679	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—melanoma	6.92e-05	0.000672	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—melanoma	6.85e-05	0.000666	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL2—melanoma	6.84e-05	0.000665	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—melanoma	6.81e-05	0.000661	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCND1—melanoma	6.67e-05	0.000648	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CTNNB1—melanoma	6.6e-05	0.000642	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—melanoma	6.47e-05	0.000629	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN1A—melanoma	6.45e-05	0.000627	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTEN—melanoma	6.44e-05	0.000625	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NFKB1—melanoma	6.41e-05	0.000622	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACER3—melanoma	6.38e-05	0.00062	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—melanoma	6.28e-05	0.00061	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UGT2B10—melanoma	5.84e-05	0.000567	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—melanoma	5.81e-05	0.000565	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—melanoma	5.76e-05	0.000559	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NRAS—melanoma	5.74e-05	0.000558	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK3—melanoma	5.5e-05	0.000534	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HS3ST5—melanoma	5.43e-05	0.000527	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—melanoma	5.35e-05	0.00052	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK1—melanoma	5.23e-05	0.000508	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—melanoma	5.23e-05	0.000508	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KRAS—melanoma	4.94e-05	0.00048	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—melanoma	4.54e-05	0.000441	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—melanoma	4.39e-05	0.000427	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRAS—melanoma	4.2e-05	0.000408	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCB4—melanoma	4.11e-05	0.0004	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—melanoma	4.02e-05	0.000391	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC6A11—melanoma	3.87e-05	0.000376	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIP4K2A—melanoma	3.87e-05	0.000376	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTAP—melanoma	3.76e-05	0.000366	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—melanoma	3.71e-05	0.00036	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PHGDH—melanoma	3.35e-05	0.000326	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LUM—melanoma	3.35e-05	0.000326	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HPSE—melanoma	3.29e-05	0.00032	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CUBN—melanoma	3.23e-05	0.000314	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SDHD—melanoma	3.12e-05	0.000303	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CSPG4—melanoma	3.12e-05	0.000303	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BSG—melanoma	3.12e-05	0.000303	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPAM—melanoma	3.02e-05	0.000293	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G6—melanoma	2.57e-05	0.000249	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—VCAN—melanoma	2.31e-05	0.000224	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP17A1—melanoma	1.95e-05	0.000189	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNA11—melanoma	1.84e-05	0.000179	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FASN—melanoma	1.8e-05	0.000175	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC5A5—melanoma	1.77e-05	0.000172	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD44—melanoma	1.71e-05	0.000166	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNAQ—melanoma	1.71e-05	0.000166	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP1B1—melanoma	1.64e-05	0.000159	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCB1—melanoma	1.35e-05	0.000131	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PRKCA—melanoma	1.24e-05	0.000121	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ERCC2—melanoma	1.23e-05	0.00012	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CG—melanoma	9.72e-06	9.44e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—melanoma	9.38e-06	9.12e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CD—melanoma	8.55e-06	8.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—melanoma	8.44e-06	8.2e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CB—melanoma	7.45e-06	7.24e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—melanoma	7.38e-06	7.17e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTEN—melanoma	6.44e-06	6.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—melanoma	4.54e-06	4.41e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—melanoma	3.71e-06	3.6e-05	CbGpPWpGaD
